Latest Breaking News On - Neurocrine biosciences company profile - Page 3 : comparemela.com

Neurocrine Biosciences, Inc (NASDAQ:NBIX) Expected to Post Q2 2024 Earnings of $1 11 Per Share

Neurocrine Biosciences, Inc (NASDAQ:NBIX) Expected to Post Q2 2024 Earnings of $1 11 Per Share
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNeurocrine biosciencesNeurocrine bioscienceWilliam blairKevin charles gormanDavidw boyerFirst horizon advisors incCommonwealth equity servicesQuadrant capital groupSecurities exchange commissionEnvestnet portfolio solutions incSunbelt securities incWells fargo companyNeurocrine biosciences incGoldman sachs groupNeurocrine biosciences company profile

Wedbush Comments on Neurocrine Biosciences, Inc s Q2 2024 Earnings (NASDAQ:NBIX)

Wedbush Comments on Neurocrine Biosciences, Inc s Q2 2024 Earnings (NASDAQ:NBIX)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNeurocrine biosciencesNeurocrine bioscienceEric benevichBluepath capital managementNeurocrine biosciences incInvestors pty ltdGoldman sachs groupNeurocrine biosciences company profileMackenzie financial corpSecurities exchange commissionCanaccord genuity groupFree reportGet free reportGenuity group

Brokers Issue Forecasts for Neurocrine Biosciences, Inc s Q2 2024 Earnings (NASDAQ:NBIX)

Brokers Issue Forecasts for Neurocrine Biosciences, Inc s Q2 2024 Earnings (NASDAQ:NBIX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesDavidw boyerEric benevichNeurocrine bioscienceWilliam blairNeurocrine biosciencesEnvestnet portfolio solutions incJpmorgan chase coCanaccord genuity groupSecurities exchange commissionQuadrant capital groupCommonwealth equity servicesFirst horizon advisors incNeurocrine biosciences company profileNeurocrine biosciences incWells fargo company

Brokers Set Expectations for Neurocrine Biosciences, Inc s FY2025 Earnings (NASDAQ:NBIX)

Brokers Set Expectations for Neurocrine Biosciences, Inc s FY2025 Earnings (NASDAQ:NBIX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesEric benevichNeurocrine biosciencesLeerink partnrsNeurocrine bioscienceIngrid delaetWells fargo companyNeurocrine biosciences company profileNeurocrine biosciences incLos angeles capital managementNorges bankWestfield capital management coSecurities exchange commissionFree reportGet free report

Citigroup Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150 00

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price increased by Citigroup from $140.00 to $150.00 in a research report released on Friday, Benzinga reports. The firm currently has a neutral rating on the stock. Other analysts also recently issued research reports about the company. Oppenheimer raised their price objective on Neurocrine Biosciences from […]

Los angelesUnited statesNeurocrine biosciencesDavidw boyerIngrid delaetNeedham companyCantor fitzgeraldVanguard group incNeurocrine biosciences incCapital partnersJpmorgan chase coLos angeles capital managementNeurocrine biosciences company profileBrown advisory incSecurities exchange commissionFree report